Dr. Lesley Grhaam

Lesley Anderson-Graham, PhD

Professor of Global Health
Epidemiology & Demography Specialist
International Experience:  England, Northern Ireland, Romania, USA

 

 

 

Education

  • Doctor of Philosophy, Cancer Epidemiology, Queen's University, Belfast, Northern Ireland, UK
  • Master of Population Health Evidence, University of Manchester, Manchester, England, UK
  • Postgraduate Certificate in Higher Education Teaching, Queen's University, Belfast, Northern Ireland, UK
  • Bachelor of Science, Honours Degree (1st class), Biomedical Science, Queen's University, Belfast, Northern Ireland, UK

Doctoral Dissertation 

  • The aetiology of Barrett's oesophagus and oesophageal adenocarcinoma – results from an all-Ireland case-control study

 

Teaching Specializations

  • Global Public Health
  • Population Health Evidence
  • Research Design and Statistics
  • Epidemiology
  • Cancer Epidemiology

Academic Experience

  • Lecturer, Public Health & Epidemiology, Queen's University, Belfast, Northern Ireland
  • E-Tutor, Epidemiology & Biostatistics, University of Liverpool/Laureate, Liverpool , England
  • E-Tutor, Biomedical Science, University of Ulster, Coleraine, Northern Ireland
  • Lecturer, Medical & Dental Training Agency, Belfast City Hospital, Belfast, Northern Ireland

Professional Experience  

  • Research Studies, Research Council UK Academic Fellowship in Cancer Prevention, Queen's University, Belfast, Northern Ireland, UK
  • Cancer Prevention Fellow, National Cancer Institute, Bethesda, Maryland, USA
  • Research Fellow, Cancer Epidemiology, Queen's University, Belfast, Northern Ireland, UK

Presentations  

  • ‘Myeloproliferative Neoplasms: the journey from the NCI CPFP’, The Ireland-Northern Ireland – National Cancer Institute Cancer Consortium Conference, May 2015.
  • ‘Myeloproliferative Neoplasms: the journey from the NCI CPFP’, DCEG, National Cancer Institute, May 2015.
  • 'HPV and the changing face of oropharyngeal cancer in Northern Ireland’ Irish Radiation Research Society, Belfast, 5th Sept 2014.
  • "The MOSAICC study', Northern Ireland Primary Care Research Forum, Belfast, 9th Oct 2013.
  • 'Haematological Cancer Research in QUB', Haematological Malignancy Research Network, 26th Sept 2013.
  • 'The MOSAICC study', NIHR, NCRN MPD Network Meeting, 19th Sept 2013.
  • 'Antibiotic use and risk of non-Hodgkin lymphoma'. Cancer Recognised Research Group Annual Retreat, Dunsilly Hotel, Antrim, 6th Nov 2009.
  • 'Infections, immunity and haematological malignancies: an epidemiologist’s perspective.' All-Ireland Cancer Conference, Four Seasons Hotel, Dublin, 2nd Dec 2008.
  • Platform presentations.
    • School of Medicine, Dentistry and Biomedical Sciences Postdoc Society Symposium, 2010.
    • All-Ireland Cancer Conference, Four Seasons Hotel, Dublin, 30th Nov-3rd Dec 2008.
    • HIV and Cancer Virology Faculty Retreat. Frederick, MD, USA. 27th October 2006.
    • Ulster society of Gastroenterology, Belfast, NI. 6th Oct. 2005. Awarded best presentation.
    • International Society of gastrointestinal oncology Annual conference, Virginia, USA. 14th – 16th July 2005.
    • Digestive Disease Week Conference, Chicago, Illinois, USA. 15th – 18th May 2005.
    • Distinguished Abstract Plenary Session. Abstract noted as newsworthy/ press conference.
    • Ulster society of Gastroenterology, Belfast, NI. 24th Feb. 2005.
    • UKACR 13th Annual Meeting, London, UK. 29th-30th Sept. 2004.
    • 20th All Ireland Social Medicine Meeting, Newcastle. 5th – 6th April 2003.
    • Ulster society of Gastroenterology, Belfast, NI. 12th March 2002.
  • Poster presentations.
    • All-Ireland Cancer Conference, Dublin, 30th Nov-3rd Dec 2008.
    • Centres for Cancer Research Fellows and Young Investigators Retreat, National Cancer Institute. 3rd-5th March 2008.
    • American Society of Hematology. Atlanta, Georgia, USA. 8th-11th December 2007.
    • National Cancer Research Institute Conference. Birmingham, England. 30th September-3rd October 2007.
    • Digestive Disease Week. Washington DC, USA. 19th-24th May 2007. Poster of distinction.
    • 3rd All Ireland Cancer Conference, Belfast, Northern Ireland. 13th-15th
    • November 2006. National Cancer Research Institute Conference, Birmingham, UK. 8th-11th October 2006.
    • All Ireland Cancer Conference, Cork. 19th – 22nd Oct.2003. 20th
    • All Ireland Social Medicine Meeting, Newcastle. 5th – 6th April 2003.
    • European cancer centre conference: cancer of the oesophagus and cardia: from gene to cure, Amsterdam. 13th – 15th Dec.2002.

Publications 

  • Published Articles
    • First large scale meta-analysis of genome-wide association studies (GWAS)in esophageal adenocarcinoma (EA) and Barrett's esophagus (BE). Gharahkhani P, Fitzgerald RC, Vaughan TL, Tomlinson I, Gockel I, Palles C, Buas MF, May A, Gerges C, Anders M, Becker J, Kreuser N, Noder T, Venerito M, Veits L, Schmidt T, Manner H, Schmidt C, Hess T, Böhmer AC, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Hackelsberger A, Mayershofer R, Pech O, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON), Wellcome Trust Case Control Consortium 2 (WTCCC2), Attwood S, Barr H, Chegwidden L, deCaestecker J, Harrison R, Love SB, MacDonald D, Moayyedi P, Prenen H, Watson RGP, Iyer PG; Anderson LA; Bernstein L ; Chow W-H; Hardie LJ; Lagergren J; Liu G; Risch HA; Wu AH; Ye W; Bird NC; Shaheen NJ; Gammon MD; Corley DA; Caldas C; Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, MacGregor S, Pharoah P, Whiteman DC, Jankowski J, Schumacher J. Lancet Oncology (In press)
    • Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis. Kendall BJ, Rubenstein JH, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Shaheen NJ, Corley DA, El-Serag HB, Whiteman DC, Thrift AP. Clinical Gastroenterology and Hepatology 2016 (In press).
    • Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett’s Esophagus. Thrift AP, Anderson LA, Murray LJ, Cook MB, Shaheen NJ, Rubenstein JH, El-Serag HB, Vaughan TL, Schneider JL, Whiteman DC, Corley DA. Am J Gastroenterol 2016 (In press).
    • HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: a population-based study from Northern Ireland. Anderson LA, O'Rorke M, Wilson R, Jamison J, Gavin AT on behalf of the Northern Ireland HPV working group. Medical Virology (In press).
    • Dietary magnesium, calcium:magnesium ratio and risk of reflux esophagitis, Barrett’s esophagus and esophageal adenocarcinoma. Dai Q, Cantwell MM, Murray LJ, Wei Z, Anderson LA, Coleman HG. British J Nutrition (In press).
    • Survival for oesophageal, stomach and small intestine cancers: results from EUROCARE-5. L. A. Anderson, A. Tavilla, H. Brenner, S. Luttmann, C. Navarro, A.T. Gavin. B. Holleczek, B.T. Johnston, M.B. Cook, F. Bannon, M. Sant on behalf of the EUROCARE 5 secretariat. European Journal of Cancer Monograph (In press).
    • Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: a population-based study. Gatta G, Botta L, Sanchez MJ, Anderson LA, Pierannunzio D, Licitra L and EUROCARE Working Group. European Journal of Cancer Monograph (In press).
    • Age-specific risk factor profiles of adenocarcinomas of the esophagus: a pooled analysis from the international BEACON consortium. Drahos J, Xiao Q, Risch HA, Freedman ND, Abnet CC, Anderson LA, Bernstein L, Brown LM, Chow WH, Gammon MD, Kamangar F, Liao L, Murray LJ, Ward MH, Ye W, Wu AH, Vaughan TL, Whiteman DC, Cook MB. IJC 2015 (Epub ahead of print).
    • Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls Anderson LA, Titmarsh GJ, Duncombe AS, Mesa R, Scherber R, Dueck AC, de Vocht F, Clarke M, McMullin MF. Am J Haematol  2015;90(10):864-870.
    • Minor allele frequency of myeloproliferative neoplasm mutations in the Irish blood donor population. Titmarsh GT, McKay GJ, Lawler M, Anderson LA, McMullin MF. Haematological Oncology 2014 (In press).
    • Alcohol and the Risk of Barrett's Esophagus: A Pooled Analysis from the International BEACON Consortium. Thrift AP, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Whiteman DC, Shaheen NJ, Corley DA. Am J Gastroenterol. 2014 Oct;109(10):1586-94.
    • Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Sant M, Minicozzi P, Mounier M, Anderson LA, Brenner H, Holleczek B, Marcos-Gragera R, Maynadié M, Monnereau A, Osca-Gelis G, Visser O, De Angelis R; EUROCARE-5 Working Group. Lancet Oncol. 2014 Aug;15(9):931-42.
    • How common are myeloproliferative neoplasms? A systematic review and meta-analysis. Titmarsh GJ, Duncombe AS, McMullin MF, O'Rorke M, Mesa R, De Vocht F, Horan S, Fritschi L, Clarke M, Anderson LA. Am J Hematol. 2014 Jun;89(6):581-7.
    • Risk of myeloid neoplasms after solid organ transplantation. Morton LM, Gibson TM, Clarke CA, Lynch CF, Anderson LA, Pfeiffer R, Landgren O, Weisenburger DD, Engels EA. Leukemia 2014 28(12):2317-23.
    • Common infection-related conditions and risk of lymphoid malignancies in older individuals. Anderson LA, Atman AA, McShane CM, Titmarsh GJ, Engels EA, Koshiol J. Br J Cancer 2014;110(11):2796-803.
    • Prior autoimmune disease and risk of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Multiple Myeloma: A systematic review and meta-analysis of the literature. McShane CM, Murray LJ, Landgren O, O’Rorke M, Korde N, Kunzmann A, Ismail MR, Anderson LA. CEBP 2014;23(2):332-42.
    • Community acquired infections associated with increased risk of lymphoplasmacytic lymphoma / Waldenström’s Macroglobulinemia. Mc Shane C, Murray LJ, Engels EA, Landgren O, Anderson LA. Br J Haematol 2014;164(5):653-8.
    • Community-acquired infections and their association with myeloid malignancies. Titmarsh G, McShane C, Engels EA, Landgren O, Murray LJ, Anderson LA. Cancer Epidemiol 2014;38(1):56-61.
    • Common community-acquired infections and risk of multiple myeloma. McShane C, Engels EA, Landgren O, Murray LJ, Anderson LA. Int J Cancer 2014;134(7):1734-40.
    • Intakes of dietary folate and other B vitamins are associated with risks of esophageal adenocarcinoma, Barrett’s esophagus and reflux esophagitis. Sharp L, Carsin A-E, Cantwell MM, Anderson LA, Murray LJ on behalf of the FINBAR study group. J Nutrition 2013;143(12):1966-73. Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research Datalink. Wilson JC, O'Rorke MA, Cooper JA, Murray LJ, Hughes C, Gormley GJ, Anderson LA. Cancer Epidemiology 2013;37(6):897-904.
    • Psychosocial factors and their association with reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma.. Denver P, Murray LJ and Donnelly M, Anderson LA on behalf of the FINBAR study group. World Journal of Gastroenterology 2013;19(11):1770-7.
    • Non-steroidal anti-inflammatory drug and aspirin use and risk of head and neck cancer. Wilson JC, Murray LJ, Hughes C, Black A, Anderson LA. British Journal of Cancer 2013;108(5):1178-81.
    • Prevalence of human papillomavirus in women attending cervical screening in the UK and Ireland: New data from northern Ireland and a systematic review and meta-analysis. Anderson LA, Jamison J and Gavin AT on behalf of the HPV steering committee. Journal of Medical Virology 2013;85(2):295-308.
    • Oesophageal cancer survival in Europe: a EUROCARE-4 study. Gavin A, Donnelly D, Francisci S, Foschi R, Karm-Kos H, Brennan A, Anderson LA. Cancer Epidemiology 2012;36(6):505-12.
    • Human papillomavirus related head and neck cancer survival. A systematic review and meta-analysis. Ellison VM, O’Rorke MA, Murray LJ, Anderson LA. Oral Oncology 2012;48(12):1191-201.
    • Second most downloaded article from Oral Oncology in 2013. Vitamin D receptor gene polymorphisms and esophageal adenocarcinoma risk: a population-based case-control study. Chang CK, Mulholland HG, Cantwell MM, Anderson LA, Johnston BT, McKnight AJ, Thompson PD, Watson RGP & Murray LJ on behalf of the FINBAR study group. Journal of Gastrointestinal Cancer 2012;43(3):512-517.
    • Genes of the Interleukin-18 pathway are associated with susceptibility to Barrett’s Esophagus: Results from the FINBAR Case-Control Study. Babar M, Ryan AW, Turner G, Anderson LA, Watson RG, Johnston BT, Comber H, McGuigan J, Murphy SJ, Murray LJ, McManus R, Reynolds JV. American Journal of Gastroenterology 2012;107(9):1331-41.
    • Cigarette smoking is associated with an increased risk of Barrett’s esophagus: a pooled analysis of individual patient data from the international BEACON consortium. Cook MB, Shaheen NJ, Anderson LA, Griffen C, Chow W-H, Vaughan TL, Whiteman DC, Corley DA. Gastroenterology 2012;142(4):744-53.
    • Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasms. Anderson LA, Duncombe AS, Hughes M, Mills ME, Wilson JC, McMullin MF. American Journal of Hematology 2012;87(2):175-82.
    • Dietary fat and meat intakes and risk of reflux esophagitis, Barrett’s esophagus and esophageal adenocarcinoma. O’Doherty MG, Cantwell MM, Murray LJ, Anderson LA, Abnet CC. International Journal of Cancer 2011;129(6):1493-502.
    • Vitamin D, calcium and dairy intake and risk of oesophageal adenocarcinoma and its pre-cursor conditions. Mulholland H, Murray LJ, Anderson LA, Cantwell MM on behalf of the FINBAR study group. British Journal of Nutrition 2011;106(5):732-41.
    • Concomitant and antecedent deep venous thrombosis and cancer survival. Anderson LA, Moore S, Gridely G, Stone BJ, Landgren O. Leukemia and Lymphoma 2011;52(5):764-70.
    • Non-Steroidal Anti-Inflammatory Drug and Aspirin Use and the Risk of Head and Neck Cancer – A Systematic Review. Wilson J.C., Anderson LA, Murray LJ, Hughes C. Cancer Causes and Control 2011;22(5):803-10.
    • Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily. Geodert JJ, Calamusa G, Dazzi C, Pelser C, Anderson LA, Madsen C, Preiss L, Airola M, Graubard BI, Messina A, Lauria C, Romano N. Infectious Agents and Cancer 2010;5:23.
    • Risk of Barrett’s oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications. Ladanchuk TC, Johnston BT, Murray LJ, Anderson LA on behalf of the FINBAR study group. Scandinavian Journal of Gastroenterology 2010;45(12):1397-403.
    • Iron intake and markers of iron status and risk of Barrett’s oesophagus and oesophageal adenocarcinoma. O’Doherty M, Abnet C, Murray LJ, Woodside J, Anderson LA, Cantwell MM on behalf of the FINBAR Study Group. Cancer Causes and Control 2010 ;21(12):2269-79.
    • Autoimmune conditions and Hairy Cell Leukemia. Anderson LA, Engels EA. Journal of Hematology & Oncology 2010, 4;3:35. Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett’s esophagus Murphy SJ, Anderson LA, Ferguson HR, Johnston BT, Watson PR, McGuigan J, Comber H, Reynolds JV, Murray LJ, Cantwell MM. Journal of Nutrition 2010;140(10):1757-63.
    • Increased risk for lymphoid and myeloid neoplasms following solid organ transplant. Quinlan S, Morton LM, Pfeiffer RM, Anderson LA, Landgren O, Warren JL, Engels EA. Cancer epidemiology, biomarkers and prevention 2010;19(5):1229-37.
    • Withdrawal of glucocorticoids in inflammatory bowel disease patients after dependency periods ranging from 2 to 45 years: A proposed method. Murphy SJ, Wang L, Anderson LA, Steinlauf A, Present DH, Mechanick JI. Alimentary Pharmacology and Therapeutics 2009;30(10):1078-86.
    • Socio-economic and other correlates of Kaposi sarcoma-associated herpesvirus seroprevalence among older adults in Sicily. Pelser C, Vitale F, Whitby D, Graubard BI, Messina A, Gafa L, Brown EE, Anderson LA, Romano N, Lauria C, Goedert JJ. Journal of Medical Virology 2009;81(11):1938-1944.
    • Common community acquired infections and subsequent risk of chronic lymphocytic leukemia. Anderson LA, Landgren O, Engels EA. British Journal of Haematology 2009;147(4):444-9.
    • Featured on MDLinx.com. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Anderson LA, Gadalla S, Morton LM, Landgren O, Pfeiffer R , Warren JL , Berndt SI, Ricker W, Parsons R , Engels EA. International Journal of Cancer 2009;125(2):398-405.
    • Glycemic index, carbohydrate and fibre intakes and risk of reflux oesophagitis, Barrett’s oesophagus and oesophageal adenocarcinoma. Mulholland HG, Cantwell MM, Anderson LA, Johnston BT, Watson RGP, Murphy SJ, Ferguson HR, McGuigan J, Reynolds JV, Comber H, Murray LJ. Cancer Causes and Control 2009;20(3):279-88.
    • Risk of myeloid malignancies in persons with autoimmune conditions. Anderson LA, Pfeiffer RM, Landgren O, Gadalla S, Berndt SI, Engels EA. British Journal of Cancer 2009;100(5):822-8.
    • The association between alcohol and reflux esophagitis, Barrett’s esophagus and esophageal adenocarcinoma: results from the FINBAR study. Anderson LA, Cantwell MM, Johnston BT, Murphy SJ, Ferguson HR, Watson RGP, McGuigan J, Comber H, Reynolds JV, Murray LJ. Gastroenterology 2009;136(3):799-805.  Article the feature of the March 2009 CME I exams.
    • Oesophageal cancer: caregiver mental health, strain and burden. Donnelly M, Anderson LA, Johnston BJ, Watson RGP, Murphy SJ, Comber H, Mc Guigan J, Reynolds JV, Murray LJ. Psychooncology 2008;17(12):1196-201.
    • Risk Factors for classical Kaposi Sarcoma – results from a population based case-control study. Anderson LA, Lauria C, Romano N, Brown EE, Whitby D, Graubard BI, Li Y, Messina A, Gaffa L, Vitale F, Goedert JJ. Cancer epidemiology, biomarkers and prevention 2008;17(12):3435-43.
    • Hematopoietic malignancies associated with viral and alcoholic hepatitis. Anderson LA, Pfeiffer R , Warren JL , Landgren O, Gadalla S, Berndt SI, Ricker W, Parsons R , Wheeler W, Engels EA. Cancer epidemiology, biomarkers and prevention 2008; 17 (11):3069-75.
    • Survival patterns among lymphoma patients with a family history of lymphoma. Anderson LA, Pfeiffer RM, Rapkin JS, Gridley G, Mellemkjaer L, Hemminki K, Bjorkholm M, Caporaso NE & Landgren O. Journal of Clinical Oncology 2008;26(30):4958-65
    • Human herpesvirus 8 infection among children in the United States. Anderson LA, Li Y, Graubard BI, Whitby D, Mbisa G, Tan S, Goedert JJ, Engels EA. Pediatric Infectious Disease Journal 2008;27(7):661-664.
    • Relationship between Helicobacter pylori infection and gastric atrophy and the stages of the oesophageal inflammation, metaplasia, adenocarcinoma sequence: results from the FINBAR case-control study. Anderson LA, Murphy SJ, Johnston BT, Watson RGP, Ferguson HR, Bamford KB, Ghazy A, McCarron P, McGuigan J, Reynolds JV, Comber H, Murray LJ. GUT 2008;57(6):734-739.
    • Inverse association between gastroesophageal reflux and blood pressure: results of a large community based study. Murray LJ, McCarron P, McCorry RB, Anderson LA, Lane A, Johnston BT, Davey-Smith G, Harvey RF. BMC Gastroenterology 2008, 8:10.
    • Patients with Barrett esophagus have poor understanding of the diagnosis and its implications. Murphy SJ, Anderson LA, Johnston BT & Murray LJ. Journal of Clinical Gastroenterology 2008; 42(4):431-432.
    • No association between hOGG1, XRCC1 and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus or esophageal adenocarcinoma: results from the FINBAR case-control study. Ferguson HR, Wild C, Anderson LA, Murphy SJ, Johnston BT, Murray LJ, Watson P, McGuigan J, Reynolds J, Hardie L. Cancer epidemiology biomarkers and prevention 2008;17(3):736-9.
    • Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux oesophagitis, Barrett’s oesophagus and esophageal adenocarcinoma. Ferguson HR, Wild C, Anderson LA, Murphy SJ, Johnston BT, Murray LJ, Watson P, McGuigan J, Reynolds J, Hardie L. Cancer epidemiology biomarkers and prevention 2008;17(3):727-31.
    • Antibiotic use and non-Hodgkin lymphoma: a population-based study. Anderson LA, Gridley G, Engels E, Morton L, Cerhan J, Cozen W, Severson, Davis S, Hartge P & Linet M. British Journal of Cancer 2008;98(1):161-4.
    • A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett’s esophagus and esophageal adenocarcinoma. Murphy SJ, Hughes AE, Patterson CC, Anderson LA, Watson RGP, Johnston BT, Comber C, McGuigan J, Reynolds JV, Murray LJ. Carcinogenesis 2007; 28(6):1323-8.
    • Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma– results from the FINBAR study. Anderson LA, Murphy SJ, Johnston BT, Watson RGP, Comber H, Reynolds JV, McGuigan J, Murray LJ. World Journal of Gastroenterology 2007 Mar 14;13(10):1585-94.
    • Malignancy and mortality in a population-based cohort of patients with coeliac disease or ‘gluten sensitivity’. Anderson LA, McMillan S, Watson RGP, Monaghan P, Gavin AT, Fox C, Murray LJ. World Journal of Gastroenterology 2007 Jan 7;13(1):146-51.
    • Non-steroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Anderson LA, Johnston BT, Watson RGP, Murphy SJ, Ferguson HR, Comber H, Reynolds JV, McGuigan J, Murray LJ. Cancer Research 2006; 66 (9):4975-4982.
    • Have patients with esophagitis got an increased risk of adenocarcinoma? Results from a population-based study. Murphy SJ, Anderson LA, Fitzpatrick DA, Johnston BT, Murray LJ. World Journal of Gastroenterology 2005;11(46):7290-5.
    • Incidence of colorectal cancer in a population-based cohort of patients with Barrett's oesophagus. Murphy SJ, Anderson LA, Mohan Lal Maine I, Fitzpatrick DA, Johnston BT, Watson RGP, Murray LJ. Scandinavian Journal of Gastroenterology 2005; 40: 1449-1453.
    • Mortality in Barrett's oesophagus: results from a population based study. Anderson LA, Murray LJ, Murphy SJ, Fitzpatrick DA, Johnston BT, Watson RGP, McCarron P, Gavin AT. Gut 2003;52(8): 1081-1084. Comment by Dr R Heading Gut 2003; 52(8): 1079-80.
  • Editorials
    • Epidemiology of MPN: What Do We Know? Anderson LA, McMullin MF. Curr Hematol Malig Rep. 2014;9(4):340-9.
    • What is the purpose of launching World Journal of Meta-Analysis? Giuseppe Biondi-Zoccai, Lesley A Anderson. World Journal of Meta-Analysis 2013.
    • Hepatitis C virus infection and non-Hodgkin lymphoma: interesting association or causal relationship? Anderson LA, Engels EA. International Journal of Cancer 2008;122(8):x-xii.
    • Tumor markers and treatments for Kaposi sarcoma. Anderson LA, Goedert JJ. AIDS 2007;21 (12):1637-9.

Membership in Academic & Professional Associations

  • Centre for Public Health Senior Management Team, Queen's University 
  • School of Medicine, Dentistry and Biomedical Science Ethics Committee, Queen's University
  • Scientific Advisory Board, Northern Ireland Biobank 
  • YMCA Committee, Carrickfergus 
  • European Association for Cancer Research Ambassador 
  • STEM Ambassador, W5 
  • Member of the Haematology Association Ireland 
  • Member NCI/All-Ireland Cancer Registries & Epidemiology Working Group 
  • Enhanced Service Quality Facilitator, Centre for Public Health, QUB 
  • Member of GetSet Women 
  • Member of the European Association for Cancer Research 
  • Fellow of the Higher Education Academy 
  • Associate investigator of the Cancer Recognised Research Group, Northern Ireland 
  • Affiliated Member of the National Postdoctoral Association, USA 
  • Ambassador of the Belfast and Northern Ireland Ambassador Programme 
  • Division of Cancer Epidemiology and Genetics Technical Evaluation of Protocols Committee, National Cancer Institute 
  • Member of the International Society of Gastrointestinal Oncology 
  • Member of the National Cancer Institute BEACON consortium of eosphageal adenocarcinoma and Barrett’s esophagus studies 

Editorial Board Membership

  • Editorial Board Member of Nature Scientific Reviews (2015-date).
  • Editorial Board Member of BMC Public Health (2015-date).
  • Editorial Board Member of International Journal of Virology and AIDS (2014-date).
  • Editor -In-Chief World Journal of Meta-analysis (2013-2014).
  • Associate Editor-In-Chief, World Journal of Methodology (2013-2014).
  • Editorial Board Member of the Journal of Tumor (2013-date).
  • Editorial Board Member of ISRN Epidemiology (2012-date)
  • Editorial Board Member of the Journal of Gastroenterology & Hepatology Research (2011-date).
  • Editorial Board Member of the World Journal of Gastroenterology (2007-2009, 2010-2012).